Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden.

Widgren K, Magnusson M, Hagstam P, Widerström M, Örtqvist Å, Einemo IM, Follin P, Lindblom A, Mäkitalo S, Wik O, Österlund A, Grünewald M, Uhnoo I, Linde A.

Euro Surveill. 2013 Apr 11;18(15):20447.

2.

Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.

Ortqvist A, Bennet R, Rinder MR, Lindblad H, Eriksson M.

Vaccine. 2012 Aug 24;30(39):5699-702. doi: 10.1016/j.vaccine.2012.07.009. Epub 2012 Jul 20.

PMID:
22819987
3.

Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.

Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K.

BMJ. 2011 Jan 25;344:d7901. doi: 10.1136/bmj.d7901.

4.

Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.

Yin JK, Chow MY, Khandaker G, King C, Richmond P, Heron L, Booy R.

Vaccine. 2012 May 2;30(21):3209-22. doi: 10.1016/j.vaccine.2012.02.048. Epub 2012 Mar 2. Review.

PMID:
22387221
5.

Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.

Song JY, Cheong HJ, Heo JY, Noh JY, Choi WS, Park DW, Lee J, Jeong HW, Kee SY, Kim WJ.

Vaccine. 2011 Feb 4;29(7):1395-8. doi: 10.1016/j.vaccine.2010.12.050. Epub 2011 Jan 1.

PMID:
21199701
6.

Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1241-5.

7.

Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.

Gilca R, Deceuninck G, De Serres G, Boulianne N, Sauvageau C, Quach C, Boucher FD, Skowronski DM.

Pediatrics. 2011 Nov;128(5):e1084-91. doi: 10.1542/peds.2010-3492. Epub 2011 Oct 10.

PMID:
21987710
8.

Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

Wichmann O, Stocker P, Poggensee G, Altmann D, Walter D, Hellenbrand W, Krause G, Eckmanns T.

Euro Surveill. 2010 May 6;15(18). pii: 19561.

9.

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.

Mahmud S, Hammond G, Elliott L, Hilderman T, Kurbis C, Caetano P, Van Caeseele P, Kettner J, Dawood M.

Vaccine. 2011 Oct 19;29(45):7975-81. doi: 10.1016/j.vaccine.2011.08.068. Epub 2011 Aug 30.

PMID:
21884747
10.

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.

Langley JM, Scheifele DW, Quach C, Vanderkooi OG, Ward B, McNeil S, Dobson S, Kellner JD, Kuhn S, Kollman T, MacKinnon-Cameron D, Smith B, Li Y, Halperin SA.

Vaccine. 2012 May 14;30(23):3389-94. doi: 10.1016/j.vaccine.2012.03.046. Epub 2012 Mar 30.

PMID:
22469860
11.

No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study.

Choe YJ, Bae GR, Lee DH.

Vaccine. 2012 Dec 14;30(52):7439-42. doi: 10.1016/j.vaccine.2012.10.030. Epub 2012 Oct 23.

PMID:
23088885
12.

Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.

Gilca V, De Serres G, Hamelin ME, Boivin G, Ouakki M, Boulianne N, Sauvageau C, Dionne M, Gilca R, Skowronski D.

Vaccine. 2011 Dec 9;30(1):35-41. doi: 10.1016/j.vaccine.2011.10.062. Epub 2011 Nov 7.

PMID:
22063386
13.

Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.

Schuurmans MM, Tini GM, Dalar L, Fretz G, Benden C, Boehler A.

J Heart Lung Transplant. 2011 Jun;30(6):685-90. doi: 10.1016/j.healun.2011.01.707. Epub 2011 Mar 27. Erratum in: J Heart Lung Transplant. 2011 Oct;30(10):1206.

PMID:
21444211
14.

Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.

Salles MJ, Sens YA, Malafronte P, Souza JF, Vilas Boas LS, Machado CM.

Transpl Infect Dis. 2012 Dec;14(6):564-74. doi: 10.1111/j.1399-3062.2012.00769.x. Epub 2012 Aug 13.

PMID:
22882692
15.

Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection.

Nelson CA, France EK, Shetterly SM, Glanz JM.

Pediatr Infect Dis J. 2011 Jul;30(7):562-5. doi: 10.1097/INF.0b013e31820bb482.

PMID:
21248657
16.

Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.

Ortqvist A, Berggren I, Insulander M, de Jong B, Svenungsson B.

Clin Infect Dis. 2011 May;52(10):1203-11. doi: 10.1093/cid/cir182.

PMID:
21507917
17.

Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital.

Vírseda S, Restrepo MA, Arranz E, Magán-Tapia P, Fernández-Ruiz M, de la Cámara AG, Aguado JM, López-Medrano F.

Vaccine. 2010 Jul 5;28(30):4751-7. doi: 10.1016/j.vaccine.2010.04.101. Epub 2010 May 14.

PMID:
20471438
18.

Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine.

Walker WT, Faust SN.

Expert Rev Vaccines. 2010 Dec;9(12):1385-98. doi: 10.1586/erv.10.141. Review.

PMID:
21105775
19.

Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.

Castilla J, Morán J, Martínez-Artola V, Fernández-Alonso M, Guevara M, Cenoz MG, Reina G, Alvarez N, Arriazu M, Elía F, Salcedo E, Barricarte A; Primary Health Care Sentinel Network of Navarre.

Vaccine. 2011 Aug 11;29(35):5919-24. doi: 10.1016/j.vaccine.2011.06.063. Epub 2011 Jun 30.

PMID:
21723358
20.

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

Carmona A, Omeñaca F, Tejedor JC, Merino JM, Vaman T, Dieussaert I, Gillard P, Arístegui J.

Vaccine. 2010 Aug 16;28(36):5837-44. doi: 10.1016/j.vaccine.2010.06.065. Epub 2010 Jun 29.

PMID:
20600478

Supplemental Content

Support Center